Cellebrite DI Ltd. (NASDAQ:CLBT) Holdings Decreased by Nine Ten Capital Management LLC

Nine Ten Capital Management LLC lessened its holdings in shares of Cellebrite DI Ltd. (NASDAQ:CLBT - Free Report) by 16.7% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 3,605,604 shares of the company's stock after selling 721,194 shares during the period. Cellebrite DI makes up approximately 22.7% of Nine Ten Capital Management LLC's portfolio, making the stock its biggest holding. Nine Ten Capital Management LLC owned 1.75% of Cellebrite DI worth $79,431,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of the business. State Street Corp increased its holdings in Cellebrite DI by 7.3% in the third quarter. State Street Corp now owns 443,700 shares of the company's stock valued at $7,472,000 after buying an additional 30,052 shares in the last quarter. Barclays PLC grew its holdings in shares of Cellebrite DI by 29.1% in the 3rd quarter. Barclays PLC now owns 263,657 shares of the company's stock worth $4,439,000 after acquiring an additional 59,395 shares during the period. Tidal Investments LLC increased its stake in Cellebrite DI by 59.3% in the 3rd quarter. Tidal Investments LLC now owns 104,478 shares of the company's stock valued at $1,759,000 after purchasing an additional 38,887 shares in the last quarter. Lord Abbett & CO. LLC acquired a new position in Cellebrite DI during the third quarter worth $11,523,000. Finally, Principal Financial Group Inc. purchased a new stake in Cellebrite DI during the third quarter worth $23,402,000. Hedge funds and other institutional investors own 45.88% of the company's stock.

Cellebrite DI Trading Up 2.5 %

Shares of Cellebrite DI stock traded up $0.48 during mid-day trading on Thursday, hitting $19.54. 241,703 shares of the stock were exchanged, compared to its average volume of 1,406,454. The stock has a market capitalization of $4.68 billion, a price-to-earnings ratio of -14.07, a price-to-earnings-growth ratio of 4.27 and a beta of 1.44. Cellebrite DI Ltd. has a twelve month low of $10.25 and a twelve month high of $26.30. The company has a 50-day simple moving average of $18.76 and a 200 day simple moving average of $20.09.

Cellebrite DI (NASDAQ:CLBT - Get Free Report) last announced its earnings results on Thursday, February 13th. The company reported $0.07 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.10 by ($0.03). Cellebrite DI had a positive return on equity of 58.70% and a negative net margin of 70.54%. Equities research analysts forecast that Cellebrite DI Ltd. will post 0.3 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

CLBT has been the subject of several research reports. Needham & Company LLC reaffirmed a "buy" rating and set a $28.00 price target on shares of Cellebrite DI in a research note on Wednesday, April 2nd. JPMorgan Chase & Co. lifted their target price on shares of Cellebrite DI from $24.00 to $28.00 and gave the stock an "overweight" rating in a research report on Tuesday, February 11th. Finally, Lake Street Capital increased their price target on shares of Cellebrite DI from $17.00 to $26.00 and gave the company a "buy" rating in a research report on Friday, February 14th. Seven equities research analysts have rated the stock with a buy rating, Based on data from MarketBeat, the company presently has an average rating of "Buy" and a consensus target price of $23.43.

Cellebrite DI Company Profile

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, cryptocurrency, and intellectual property theft.